Pharma and Healthcare - Podcast: From clinical trials to commercialisation
The road from clinical trials to final delivery of pharma products into the marketplace must be carefully followed — with a complex journey that includes scientific labs, manufacturing sites, distribution centers, and ultimately, patients.
From 1 January 2021, full import controls and subsequently full customs declarations are required on all goods crossing the borders between the United Kingdom and the European Union. To avoid any unnecessary delays, disruptions at the border or hampered deliveries, Kuehne+Nagel has created a unique, automated and digital data processing solution to make customs clearance a seamless experience for you.
